PET-CT

PET-CT combines positron emission tomography (PET) detectors and computed tomography (CT) into one imaging system. 

GE Healthcare also recently announced Xeleris V, a new virtualized, flexible AI-powered solution that provides clinicians secure access to data from anywhere – helping them make personalized care decisions and treatment recommendations that are at the heart of precision health.
News | Nuclear Imaging
GE Healthcare Advances Precision Health & Theranostics With New Products & Solutions

June 22, 2021 — At the Society of Nuclear Medicine and Molecular Imaging’s (SNMMI) 2021 summer conference, GE Healthcare ...

Time June 22, 2021
arrow
A phase III clinical trial has validated the effectiveness of the prostate-specific membrane antigen (PSMA)-targeted radiotracer 18F-DCFPyL in detecting and localizing recurrent prostate cancer.
News | Prostate Cancer
PSMA-Targeted Radiotracer Pinpoints Metastatic Prostate Cancer Across Anatomic Regions

June 21, 2021 — A phase III clinical trial has validated the effectiveness of the prostate-specific membrane antigen ...

Time June 21, 2021
arrow
Positron emission tomography (PET) using a 68Ga-labeled fibroblast activation protein inhibitor (FAPI) can noninvasively identify and monitor pulmonary fibrosis, according to research presented at the Society of Nuclear Medicine and Molecular Imaging 2021 Annual Meeting.
News | PET-CT
Radiotracer Effective for Detection and Assessment of Lung Fibrosis

June 14, 2021 — Positron emission tomography (PET) using a 68Ga-labeled fibroblast activation protein inhibitor (FAPI) ...

Time June 14, 2021
arrow
News | PET-CT
Canon Medical’s Digital PET/CT System Receives FDA Clearance

June 10, 2021 — Bringing the power of artificial intelligence (AI) to molecular imaging, Advanced intelligent Clear-IQ ...

Time June 10, 2021
arrow
According to an open-access article in ARRS’ American Journal of Roentgenology (AJR), increased axillary lymph node or ipsilateral deltoid uptake is occasionally observed on FDG or 11C-choline PET performed after Pfizer-BioNTech or Moderna COVID-19 vaccination
News | Coronavirus (COVID-19)
Nodal and Deltoid Radiotracer Uptake on Post-COVID-19 Vaccination PET

May 19, 2021 — According to an open-access article in ARRS’ American Journal of Roentgenology (AJR), increased axillary ...

Time May 19, 2021
arrow
Videos | Coronavirus (COVID-19)
VIDEO: COVID Vaccine Adenopathy Can Last Up to 10 Weeks

Yael Eshet, M.D., MSc, a diagnostic radiology specialist at Sheba Medical Center in Israel, was the lead author on a ...

Time May 11, 2021
arrow
News | PET-CT
PET/CT Shows Stressed Brain Linked to Broken Heart

March 29, 2021 — Heightened activity in the brain, caused by stressful events, is linked to the risk of developing a ...

Time March 29, 2021
arrow
Siemens Healthineers has announced the Food and Drug Administration (FDA) clearance of the Biograph Vision Quadra, a positron emission tomography/computed tomography (PET/CT) scanner designed for clinical use as well as translational research – or the application of scientific research to create therapies and procedures that improve health outcomes. In this manner, the Biograph Vision Quadra expands precision medicine.
News | PET-CT
Siemens Healthineers Announces FDA Clearance of Biograph Vision Quadra Extended Axial FoV PET/CT Scanner

March 8, 2021 — Siemens Healthineers has announced the Food and Drug Administration (FDA) clearance of the Biograph ...

Time March 08, 2021
arrow
Findings indicate that PPC and GG are highly predictive of overall upstaging by PSMA PET/CT for patients with high-risk prostate cancer
News | PET-CT
Model Helps Predict Which Patients will Benefit Most from PSMA PET Scan

February 23, 2021 — A new study led by researchers at the UCLA Jonsson Comprehensive Cancer Center helps identify which ...

Time February 23, 2021
arrow
News | Nuclear Imaging
The Journal of Nuclear Medicine Celebrates 60 Years of Research

December 14, 2020 — The Journal of Nuclear Medicine (JNM) has issued a special supplement commemorating six decades of ...

Time December 14, 2020
arrow
Videos | PET-CT
VIDEO: Example of PET-CT Artificial Intelligence Driven Image Reconstruction

This is an example of Canon's Advanced intelligent Clear-IQ Engine (AiCE) AI-driven image reconstruction software that ...

Time December 04, 2020
arrow
ASG well positioned for growth as healthcare marketplace continues to evolve 
News | Radiology Imaging
Alpha Source Group Names New CEO, Expands Customized Service Solutions to Focus on OEM Partnerships

November 24, 2020 — Alpha Source Group (ASG), a comprehensive next-generation services partner, has named Allan Klotsche ...

Time November 24, 2020
arrow
 MIM Software Inc. announced a collaboration with Peter MacCallum Cancer Centre (Peter Mac) in support of its Prostate Cancer Theranostics and Imaging Centre of Excellence (ProsTIC) program.
News | Prostate Cancer
MIM Software Inc. Announces Collaboration with Peter MacCallum Cancer Centre to Improve Patient Management

November 19, 2020 — MIM Software Inc. announced a collaboration with Peter MacCallum Cancer Centre (Peter Mac) in ...

Time November 19, 2020
arrow
"Initial report of a randomized trial comparing conventional- vs conventional plus fluciclovine (18F) PET/CT imaging-guided post-prostatectomy radiotherapy for prostate cancer" was presented by Ashesh Jani, M.D., Winship Cancer Institute of Emory University, at ASTRO20
News | PET Imaging
Adding Advanced PET Scans to Radiation Treatment Plans for Prostate Cancer Increases Failure-free Survival Rates

October 26, 2020 — Adding the advanced PET radiotracer fluciclovine to conventional imaging to help guide radiation ...

Time October 26, 2020
arrow
Moffitt Cancer Center researchers are developing a noninvasive, accurate method to analyze a patient's tumor mutations and biomarkers to determine the best course of treatment.
News | Lung Imaging
Researchers Develop Tool to Better Predict Treatment Course for Lung Cancer

October 19, 2020 — Personalized treatment options for patients with lung cancer have come a long way in the past two ...

Time October 19, 2020
arrow
During virtual RSNA 2020, Canon Medical Systems USA, Inc. will showcase enhancements to the Cartesion Prime PET/CT system, a premium Digital PET/CT scanner designed to help health care providers deliver more personalized care.
News | PET-CT
Cartesion Prime Helps Expand Enhanced Clinical Insights While Maximizing Business Performance

October 5, 2020 — During virtual RSNA 2020, Canon Medical Systems USA, Inc. will showcase enhancements to the Cartesion ...

Time October 05, 2020
arrow
Indeterminate lesion on PET/CT classified by PET/MRI for 53-y-old man with lung cancer.
News | PET-MRI
PET/MRI Improves Lesion Detection, Reduces Radiation Exposure

September 18, 2020 — A single-center observational study of more than 1,000 oncological examinations has demonstrated ...

Time September 18, 2020
arrow
A 12-year-long collaboration with Canon Medical Research USA, Canon Medical Systems Japan and Southern Nevada outpatient radiology leader Steinberg Diagnostic Medical Imaging (SDMI) has resulted in the development of 3 PET scanners, each generation more advanced than the last
News | PET-CT
Steinberg Diagnostic Medical Imaging First to Offer Canon Digital PET/CT

September 8, 2020 — A 12-year-long collaboration with Canon Medical Research USA, Canon Medical Systems Japan and ...

Time September 08, 2020
arrow
a) Includes scintigraphy and PET with and without concomitant CT. b) Includes conventional radiography, dual-energy x-ray absorptiometry, fluoroscopy, and radiography performed during radiologic interventions. c) Includes general, cardiothoracic, maxillary, plastic, and orthopedic surgery and neurosurgery. d) Includes allergology, cardiology, geriatrics, general internal medicine, pulmonology, gastroenterology, and rheumatology
News | Radiology Imaging
Unread Second-opinion Radiology Reports Waste Healthcare Resources

August 14, 2020 — According to ARRS' American Journal of Roentgenology (AJR), clinicians do not read a considerable ...

Time August 14, 2020
arrow
PSMA PET/CT accurately detects recurrent prostate cancer in 67-year-old man. 18F-DCFPyL-PSMA PET/CT shows extensive, intensely PSMA-avid local recurrence in prostate (bottom row; solid arrow) in keeping with the known tumor recurrence in the prostate. Right: PET shows extensive, intensely PSMA-avid local recurrence in prostate (top row; solid arrow) and a solitary bone metastasis in left rib 2 (bottom row; dotted arrow). Image courtesy of Ur Metser, et al.
News | PET-CT
PSMA PET/CT Can Change Management in Recurrent Prostate Cancer

July 16, 2020 — New research confirms the high impact of PSMA PET/CT in the detection and management of recurrent ...

Time July 16, 2020
arrow
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now